Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ascorbic acid to reduce vancomycin-induced nephrotoxicity
IRCT20241109063646N1Phase 4Completed
- Sponsor
- Shahid Sadoughi University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ascorbic acid in acute kidney failure (AKF) and drug-induced nephropathy (DIN), sponsored by Shahid Sadoughi University of Medical Sciences. Started Dec 2024; status: completed.
02
Drugs
ascorbic acid
03
Conditions
acute kidney failure (AKF)drug-induced nephropathy (DIN)
Beyond the preview
Go deeper on IRCT20241109063646N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20241109063646N1.